Zebra Capital Management LLC Neogenomics Inc Transaction History

Zebra Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$19.57 - $24.1 $384,883 - $473,974	-19,667 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$12.14 - $20.46 $9,906 - $16,695	816 Added 4.33%	19,667 $402,000
Q4 2018 Feb 14, 2019	BUY	$11.24 - $18.5 $85,513 - $140,748	7,608 Added 67.67%	18,851 $238,000
Q3 2018 Nov 14, 2018	BUY	$12.5 - $15.38 $140,537 - $172,917	11,243 New	11,243 $173,000

277

120M

751K

107K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $805M
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Zebra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Zebra Capital Management LLC with notifications on news.